Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani in a Visit to Jebbit Bsharri: We Believe in Transparency and Work to Improve the Performance of Institutions and the Role of the Private and Governmental Hospitals

 
NNA – Deputy Prime Minister Health Minister Ghassan Hasbani visited Jebbit Bsharri accompanied by the Director of his office Michel Aad, Counselors Frederic Eid and Georges Akoury. His first stop was in Al-Arz Medical Center in Qanat where he was greeted by Deputies Sethrida Geagea and Elie Keyrouz, the Lebanese Forces Candidate for the district Joseph Isaac, Head of the Municipality Federation in the District Elie Makhlouf, Head of Qanat Municipality Dr. Antoine Saadeh, members of the Municipality Council and Mayors, President of Cedars Medical Association Rita Garana, the Lebanese Forces coordinators, Heads of centers in Jebbit Bshari, President of Qanat Dispensary Zeina El Alam, member of the Lebanese Dental Association council Joseph El Hayek and a number of Lebanese forces activists , people from the region and nearby villages.
 
Hasbani then announced “the launch of the pilot phase for the telemedicine project that connects the primary healthcare centers to the University hospitals, while providing a gatekeeper model for the health system and high-quality services for the remote villages.” Hasbani also noted the aids granted by the World Bank and UNICEF in this context.

“ We are introducing today from this place this new initiative for the telemedicine pilot phase through electronic devices. This is the first in its kind in Lebanon and the Middle East. This project enables citizens in the healthcare centers in the remote villages to undergo more than 16 medical examinations, and communicate directly with specialist doctors in University Hospitals in Beirut. In the future, they will be able to communicate with specialist doctors abroad, in the event that their case is incurable in Lebanon”, Hasbani said.

Hasbani then headed to Hadath el Jebbeh, before he moved with Geagea and Keyrouz to St. Daniel Dispensary and Hasroun, where he visited the dispensary and the new building of Mar Mema Hospital in Bsharri.

“We believe in transparency and work hard to improve the performance of institutions and the role of Governmental and private hospitals. Our 2025 health strategy includes the introduction of technology in hospitals and the Universal health Coverage for all the citizens, in particular uninsured people.”
 
    2
    ...
ATC Name B/G Ingredients Dosage Form Price
R01AA07 OTRIVIN B Xylometazoline HCl - 0.1% 0.1% Drops 241,892 L.L
R01AA07 OTRIVIN MENTHOL 0.1% B Xylometazoline HCl - 0.1% 0.1% Drops 387,027 L.L
R01AA07 OTRIVIN B Xylometazoline HCl - 0.05% 0.05% Drops 181,419 L.L
S01AE01 OFLOX B Ofloxacin - 3mg/ml 0.3% Drops solution 366,869 L.L
S01AE01 OFLOX B Ofloxacin - 0.3% 0.3% Drops solution 366,869 L.L
A11CC03 ONE-ALPHA B Alfacalcidol - 2mcg/ml 2mcg/ml Drops solution 1,343,843 L.L
S01GX09 OLOPAT G Olopatadine (HCl) - 0.1% 0.1% Drops solution 344,024 L.L
S01GX09 OLOPAT UD G Olopatadine (HCl) - 0.1% 0.1% Drops solution 1,523,917 L.L
S02AA16 OFLOMED G Ofloxacin - 3mg/ml 3mg/ml Drops solution 317,403 L.L
S01AE01 OPTIFLOX G Ofloxacin - 3mg/ml 3mg/ml Drops suspension 143,791 L.L
S01CA01 OPTIDEX T G Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml Drops suspension 266,081 L.L
M02AA15 OLFEN G Diclofenac sodium (diethylamine) - 1% 1% Gel 268,769 L.L
G03CA03 OESTRODOSE B Estradiol (17 bêta estradiol anhydre) - 0.06% 0.06% Gel 642,357 L.L
G03CA03 OESTRACLIN G Estradiol - 0.6mg/g 0.6mg/g Gel 448,843 L.L
S01BA01 OZURDEX B Dexamethasone - 700mcg 700mcg Implant 80,696,540 L.L
S01BA01 OZURDEX B Dexamethasone - 700mcg 700mcg Implant 80,696,540 L.L
S01BA01 OZURDEX B Dexamethasone - 700mcg 700mcg Implant L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution 547,517,314 L.L
L01XA03 OXALIPLATIN G Oxaliplatin - 5mg/ml 5mg/ml Injectable concentrated solution 6,137,329 L.L
L01XA03 OXALIPLATIN G Oxaliplatin - 5mg/ml 5mg/ml Injectable concentrated solution 3,450,988 L.L
L01XA03 OXALIPLATIN EBEWE G Oxaliplatin - 50mg/10ml 50mg/10ml Injectable concentrated solution 3,405,297 L.L
L01XA03 OXALIPLATIN EBEWE G Oxaliplatin - 50mg/10ml 50mg/10ml Injectable concentrated solution L.L
B05BA10 OLIMEL N9E B Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l Injectable emulsion 4,711,512 L.L
B05BA10 OLIMEL N9 B Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Azote - 9g/l Injectable emulsion 5,630,028 L.L
B05BA10 OLIMEL N9E B Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 54mmol/l, Chloride - 45mmol/l, Azote - 9g/l Injectable emulsion 3,550,432 L.L
B05BA10 OLIMEL N7E B Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 45mmol/l, Chloride - 45mmol/l, Azote - 7g/l Injectable emulsion 3,534,306 L.L
B05BA10 OLIMEL N7E B Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 89mmol/2l, Chloride - 90mmol/2l, Azote - 14g/2l Injectable emulsion 4,711,512 L.L
B02BD04 OCTANINE F BioHuman Plasma coagulation factor IX, human - 500IU 500IU Injectable freeze dried powder + diluent 31,425,075 L.L
L01XA03 OXALTIE G Oxaliplatin - 50mg 50mg Injectable lyophilised powder 2,957,797 L.L
    2
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026